HemoSmart Medical Technology is an international leading company focusing on the development of in vitro diagnostic microfluidic systems. Its business scope includes: automatic microdroplet high-speed production intelligent system; circulating tumor cell rapid screening system; microbial rapid detection kit; trace detection kit for misfolded protein in neurodegenerative diseases; preparation of microcapsules. The donation supports Yang’s group at UCL in general. Research in his group is aiming to develop nature-inspired adaptive materials & systems for innovative solutions to address grand challenges in health, environment and sustainability.